Many benzimidazole-based compounds act as antihypertensives by intercepting the renin angiotensin aldosterone system (RAS) in which angiotensin II (Ang II), by acting on the AT1 receptor, causes vasoconstriction, Na+ retention, aldosterone release, and the development of hypertension. This evidence concerns the gene AGT and hypertensive disorder.